Market Place
Sourcing Support
Tonix Pharma Presents TNX-102 SL Data for Fibromyalgia at ACR 2024
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma to Present at Winter 2024 Investor Summit Virtual
18 Nov 2024 //
GLOBENEWSWIRE
Tonix Targets Rapid Migraine Relief With Non-Oral Treatments
14 Nov 2024 //
ACCESSWIRE
Tonix Pharma Publishes Mpox & Smallpox Vaccine Study in mSphere
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Announces Poster at ACR Convergence Annual Meeting
13 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Reports Q3 2024 Financial Results & Operational
12 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharma Announces Mpox Phase I Study Agreement with KEMRI
04 Nov 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
29 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
25 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At World Vaccine Congress
24 Oct 2024 //
GLOBENEWSWIRE
Tonix Receives Contract Payment For Antiviral Development
17 Oct 2024 //
GLOBENEWSWIRE
Tonix Submits TNX-102 SL NDA For Fibromyalgia To The FDA
16 Oct 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces AI Collaboration With X-Chem
08 Oct 2024 //
GLOBENEWSWIRE
Two Companies Near FDA Decisions On Non-Addictive Painkillers
01 Oct 2024 //
ACCESSWIRE
Tonix Pharma Joins Endpoints Panel At Long COVID Workshop
30 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch
27 Sep 2024 //
GLOBENEWSWIRE
Tonix Announces TNX-102 SL Presentations At PDDS 2024
23 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Issuance Of U.S. Patent
19 Sep 2024 //
GLOBENEWSWIRE
Tonix`s Mpox Vaccine Aligns With WHO`s Target Profile
16 Sep 2024 //
GLOBENEWSWIRE
Tonix Appoints Thomas Englese As EVP Commercial Operations
10 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents Data On Potential Mpox Vaccine TNX-801
09 Sep 2024 //
GLOBENEWSWIRE
Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds
06 Sep 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data for Stress Reduction and Wound Healing at MHSRS
29 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024
28 Aug 2024 //
GLOBENEWSWIRE
Tonix and Bilthoven Collaborate on Mpox Vaccine Development, TNX-801
26 Aug 2024 //
GLOBENEWSWIRE
Tonix And Bilthoven Biologicals To Collaborate On Mpox Vaccine Development
26 Aug 2024 //
GLOBENEWSWIRE
Tonix To Present At 2024 Military Health Research Symposium
21 Aug 2024 //
GLOBENEWSWIRE
Tonix Enrolls First Patient In Phase 2 CATALYST Study Of TNX-1300
20 Aug 2024 //
GLOBENEWSWIRE
Tonix Reports Q2 2024 Results And Operational Highlights
19 Aug 2024 //
GLOBENEWSWIRE
Tonix Updates On Mpox Vaccine TNX-801 As WHO Declares Outbreak Emergency
16 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
13 Aug 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data For Fibromyalgia At IASP 2024 Congress
12 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharma Publishes On Human Antibody Generation Technology
06 Aug 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At IASP 2024 World Congress
30 Jul 2024 //
GLOBENEWSWIRE
Tonix Gets FDA Fast Track For Tonmya In Fibromyalgia
25 Jul 2024 //
GLOBENEWSWIRE
Tonix Plans NDA Filing For Fibromyalgia Drug, Targets 2025 Launch
17 Jul 2024 //
ACCESSWIRE
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
10 Jul 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces $4.0 Million Public Offering Pricing
09 Jul 2024 //
GLOBENEWSWIRE
Tonix Reports Positive Pre-NDA Meeting With FDA For Fibromyalgia Drug
08 Jul 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Proposed Public Offering
08 Jul 2024 //
GLOBENEWSWIRE
Tonix Awarded $34M DoD Contract For Antiviral Program
01 Jul 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
28 Jun 2024 //
GLOBENEWSWIRE
Tonix Announces Pricing of Approximately $4.0 Million Public Offering
27 Jun 2024 //
GLOBENEWSWIRE
Tonix Announces Positive Pre-NDA Meeting With FDA For Tonmya™ In Fibromyalgia
20 Jun 2024 //
GLOBENEWSWIRE
Tonix Presents Migraine Treatment Data At AHS Meeting
18 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharma Presents Poster On Tonmya™ For Fibromyalgia At EULAR 2024
17 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Closes $4M Public Offering
13 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
12 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Proposed Public Offering
11 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
06 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Presentations Involving TNX-1500 At ATC 2024
06 Jun 2024 //
GLOBENEWSWIRE
AbBC: Showcasing Cancer/Disease Approaches At Goldman Sachs Conference
05 Jun 2024 //
GLOBENEWSWIRE
Tonix`s Tonmya Shows Fibromyalgia-Associated Depression Activity
03 Jun 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data At ASCP Annual Meeting
30 May 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-1500 Data At American Transplant Congress 2024
29 May 2024 //
GLOBENEWSWIRE
Tonix Pharma: Presenting At 2024 BIO International Convention
28 May 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals To Present At AGP Healthcare Showcase
15 May 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Q1 2024 Financials, Operations
13 May 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
24 Apr 2024 //
GLOBENEWSWIRE
Tonix Reports Fourth Quarter and Full Year 2023 Financial Results
01 Apr 2024 //
GLOBENEWSWIRE
